Evidence map›Paper›PMID 33511551›Full record

ArticleMolecular and cellular biochemistry2021

Adenosine A

Ahmad Hanif, Stephanie O Agba, Catherine Ledent, Stephen L Tilley, Christophe Morisseau, Mohammed A Nayeem

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Molecular and cellular biochemistry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.1field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Dipyridamole and adenosinergic pathway in Covid-19: a juice or holy grail.The Egyptian journal of medical human genetics · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Ahmad HanifPharmaceutical Sciences, School of Pharmacy, Center for Basic and Translational Stroke Research, West Virginia University Morgantown, Morgantown, WV, USA.
Stephanie O AgbaPharmaceutical Sciences, School of Pharmacy, Center for Basic and Translational Stroke Research, West Virginia University Morgantown, Morgantown, WV, USA.
Catherine LedentIRIBHN, Universite Libre de Bruxelles, Bruxelles, Belgium.
Stephen L TilleyDivision of Pulmonary and Critical Care Medicine, UNC at Chapel Hill, Chapel Hill, NC, USA.
Christophe MorisseauUniversity of California at Davis, One Shields Avenue, Davis, CA, USA.
Mohammed A NayeemPharmaceutical Sciences, School of Pharmacy, Center for Basic and Translational Stroke Research, West Virginia University Morgantown, Morgantown, WV, USA. mnayeem@hsc.wvu.edu.ORCID http://orcid.org/0000-0002-7827-4760
West Virginia University · USUniversité Libre de Bruxelles · BEUniversity of California, Davis · USUniversity of North Carolina Health Care · US

Funding

Role of Cyp2j-epoxygenases, sEH and PPARs in adenosine-induced vascular responseR01HL114559 · NHLBI · WEST VIRGINIA UNIVERSITY · PI NAYEEM, MOHAMMED A · 2013 to 2017
$1.5M
NHLBI NIH HHS HL-114559
6 · The paper itself

Abstract

Previously, we have reported that the coronary reactive hyperemic response was reduced in adenosine A

Indexed as

Angiotensin IIAnimalsEpoxide HydrolasesMiceMice, KnockoutReceptor, Adenosine A1Receptor, Adenosine A2AVasoconstrictionAdora2a protein, mouseAngiotensin IIEphx2 protein, mouseEpoxide HydrolasesReceptor, Adenosine A1Receptor, Adenosine A2AAdenosine A1 receptorAdenosine A2A receptorAngiotensin-IISoluble epoxide hydrolaseVascular response

Identifiers

PMID33511551
OpenAlexW3122335995

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.